Guarini A - Search Results

1

Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy.

Pulsoni A, Della Starza I, Cappelli LV, Tosti ME, Annechini G, Cavalli M, De Novi LA, D'Elia GM, Grapulin L, Guarini A, Del Giudice I, Foà R. Pulsoni A, et al. Among authors: guarini a. Br J Haematol. 2020 Jan;188(2):249-258. doi: 10.1111/bjh.16125. Epub 2019 Aug 5. Br J Haematol. 2020. PMID: 31385309 Free article.

2

Has IL2 a role in the management of minimal residual disease for acute leukemia?

Foa R, Meloni G, Guarini A, Mandelli F, Gavosto F. Foa R, et al. Among authors: guarini a. Leukemia. 1992 Nov;6 Suppl 4:92-4. Leukemia. 1992. PMID: 1434844 Review.

3

IL2 treatment for cancer: from biology to gene therapy.

Foa R, Guarini A, Gansbacher B. Foa R, et al. Among authors: guarini a. Br J Cancer. 1992 Dec;66(6):992-8. doi: 10.1038/bjc.1992.400. Br J Cancer. 1992. PMID: 1457368 Free PMC article. Review.

4

Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study.

Meloni G, Foà R, Tosti S, Vignetti M, Mancini F, Guarini A, Marchis D, Gavosto F, Mandelli F. Meloni G, et al. Among authors: guarini a. Leukemia. 1992 Aug;6(8):780-5. Leukemia. 1992. PMID: 1640729

5

Thrombocytopenia in acute leukaemia patients treated with IL2: cytolytic effect of LAK cells on megakaryocytic progenitors.

Guarini A, Sanavio F, Novarino A, Gillio Tos A, Aglietta M, Foa R. Guarini A, et al. Br J Haematol. 1991 Nov;79(3):451-6. doi: 10.1111/j.1365-2141.1991.tb08054.x. Br J Haematol. 1991. PMID: 1751372

6

Treatment of residual disease in acute leukemia patients with recombinant interleukin 2 (IL2): clinical and biological findings.

Foa R, Meloni G, Tosti S, Novarino A, Fenu S, Guarini A, Cardona S, Gillio Tos A, Gavosto F, Mandelli F. Foa R, et al. Among authors: guarini a. Bone Marrow Transplant. 1990 Jul;6 Suppl 1:98-102. Bone Marrow Transplant. 1990. PMID: 2202476 Clinical Trial. No abstract available.

7

Cytokines and DIC in acute leukaemia.

Guarini A, Gugliotta L, Bianchi A, De Groote D, Foa R. Guarini A, et al. Eur J Haematol. 1990 Aug;45(2):121-2. doi: 10.1111/j.1600-0609.1990.tb00435.x. Eur J Haematol. 1990. PMID: 2209819 No abstract available.

8

Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin.

Foa R, Caretto P, Fierro MT, Bonferroni M, Cardona S, Guarini A, Lista P, Pegoraro L, Mandelli F, Forni G, et al. Foa R, et al. Among authors: guarini a. Br J Haematol. 1990 May;75(1):34-40. doi: 10.1111/j.1365-2141.1990.tb02613.x. Br J Haematol. 1990. PMID: 2375921

9

The inhibitory effect of serum from hairy-cell leukaemia patients on normal progenitor cells may disappear following prolonged treatment with alpha-interferon.

Lauria F, Bagnara GP, Catani L, Gaggioli L, Guarini A, Raspadori D, Foa' R, Bellone G, Buzzi M, Gugliotta L, et al. Lauria F, et al. Among authors: guarini a. Br J Haematol. 1989 Aug;72(4):497-501. doi: 10.1111/j.1365-2141.1989.tb04312.x. Br J Haematol. 1989. PMID: 2775655

10

Cytotoxic effectors activated by low-dose IL-2 plus IL-12 lyse IL-2-resistant autologous acute myeloid leukaemia blasts.

Vitale A, Guarini A, Latagliata R, Cignetti A, Foa R. Vitale A, et al. Among authors: guarini a. Br J Haematol. 1998 Apr;101(1):150-7. doi: 10.1046/j.1365-2141.1998.00645.x. Br J Haematol. 1998. PMID: 9576195 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

452 results

Search Page

Filters